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Eradication of the latentHIV reservoir remains amajor
barrier to curing AIDS. However, the mechanisms
that direct viral persistence in the host are not well
understood. Studying a model system of postinte-
gration latency, we found that viral integration into
the actively transcribed host genes led to transcrip-
tional interference (TI) caused by the elongating
RNA polymerase II (RNAPII) transcribing through
the viral promoter. The resulting physical exclusion
of preinitiation complex formation on the 50 long
terminal repeat (LTR) promoted the silencing of HIV
transcription. This block could be counteracted by
inhibiting the upstream transcription or cooperatively
activating viral transcription initiation and elongation.
Importantly, PCR-based analysis, which detects
host transcription through the 50LTR independently
of the viral integration site, revealed substantial
levels of this transcription in HIV-infected primary
CD4+ T cells. Collectively, our findings suggest that
TI contributes significantly to HIV latency and should
be considered when attempting to purge the latent
reservoir.
INTRODUCTION
The latent HIV reservoir, which represents only a small pool of in-
fected cells, is a key obstacle to curing AIDS (Finzi et al., 1999).
Replication-competent viruses persist mostly in resting CD4+
T cells, where they fail to be recognized and eliminated by the
immune system (Chun et al., 1995). To eradicate this reservoir,
several studies have attempted to reactivate viral replication
and thus render previously latent HIV susceptible to highly active
antiretroviral therapy (HAART). However, the eradication of the
latent reservoir has not been accomplished to date. Thus, it is
of great importance to understand the mechanisms underlying
viral persistence in the host.
One of themajor contributors to the latent reservoir is a postin-
tegration form of latency occurring when CD4+ T cells revert to
a resting memory state after the integration of the viral genome
into the host genome (Finzi et al., 1999). This latency is achieved
and maintained by several mechanisms (Lassen et al., 2004;
Contreras et al., 2006), with predominant ones operating at the
level of transcription. A key obstacle to efficient transcriptionCell Hoinitiation and elongation is establishment of a repressive chro-
matin environment in the form of two nucleosomes occupying
the position in the 50 long terminal repeat (LTR) and adjacent se-
quence (Verdin et al., 1993). This repressive chromatin is main-
tained in part by the recruitment of histone deacetylases
(HDACs) via a variety of DNA-bound transcription factors such
as p50:p50 homodimers (Williams et al., 2006). However, rever-
sion to a permissive chromatin by HDAC inhibitors is not suffi-
cient for productive transcription. Indeed, the latter requires
the recruitment of activators such as Sp1, NF-kB, and NFAT,
which promote various steps of HIV transcription. Among
them, the role of NF-kB has been studied extensively. Upon
stimulation with different agents such as TNF-a and PMA, NF-
kBbindswith a strong affinity to kB sites on the 50LTR in its active
heterodimeric form (RelA:p50), displaces p50:p50-HDAC1 com-
plexes, and governs the preinitiation complex (PIC) formation
and successful transcription initiation (Williams et al., 2006). At
this stage, an initiating RNA polymerase II (RNAPII) is phosphor-
ylated on the serine 5 in the heptapeptide repeats of its C-termi-
nal domain (CTD) but does not elongate into the gene effectively.
Notably, inefficient elongation occurs despite the modest re-
cruitment of the positive transcription elongation factor b (P-
TEFb) that phosphorylates serine 2 in the heptapeptide repeats
of CTD (Peterlin and Price, 2006). Nevertheless, a sustained ac-
tivation of NF-kB leads to the synthesis of viral transactivator of
transcription (Tat), which effectively recruits P-TEFb to the close
proximity of CTD, resulting in increased phosphorylation of the
CTD and productive transcription elongation. Thus, repressive
chromatin environment, lack of host transcription factors (TFs),
and/or of viral Tat could contribute to postintegration latency.
In addition to the well-recognized mechanisms directing HIV
latency, it has been reported that the HIV genome is preferen-
tially integrated into the actively transcribed host genes (Han
et al., 2004; Lewinski et al., 2005; Schroder et al., 2002). These
integrations could lead to occurrences of a phenomenon called
transcriptional interference (TI), where an ongoing transcription
from a host promoter would prevent PIC assembly on the
50LTR, thus interfering with the viral transcription. A similar situ-
ation has been demonstrated in the case of HIV LTRs, where ac-
tive transcription originating from the 50LTR interferes with tran-
scription from the 30LTR (Cullen et al., 1984; Greger et al., 1998).
Notably, the finding that the HIV-based genome frequently inte-
grated into highly expressed genes in the infected Jurkat T cells
led investigators to propose that TI could play an important role
in silencing viral transcription (Lewinski et al., 2005). There is
analysis of viral-integration sites in resting CD4+ T cells from pa-
tients on HAART in support of this hypothesis. Strikingly, 93% ofst & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc. 123
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et al., 2004). Thus, TI might be the major contributor in the estab-
lishment of HIV latency.
In this study, we employed an established Jurkat CD4+ T cell
model (J-Lat cells) of postintegration latency (Jordan et al.,
2003) to directly assess the importance of TI in silencing of the
HIV provirus. Our results indicate that active transcription from
the upstream host gene interferes with transcription from the
50LTR in two cell lines investigated. Moreover, a detailed analysis
of these host transcripts enabled us to devise a strategy for
detecting TI independently of viral-integration sites. Using this
method, we demonstrate significant levels of active host tran-
scription at the 50LTR in infected primary CD4+ T cells. Finally,
we established approaches toward counteracting TI to eliminate
the latent viral reservoir. Thus, we provide evidence for an essen-
tial role of TI in HIV latency.
RESULTS
HIV Genome Is Integrated into an Actively Transcribed
Gene in J-Lat 9.2 and 15.4 Cells
To explore the role of TI in promoting a postintegration formofHIV
latency,we tookadvantageofJ-Lat cells,whichexhibit very lowto
undetectable levels of viral gene expression (Jordan et al., 2003).
These cells contain a full-lengthHIV provirus inwhich thenefgene
has been replaced with theGFP gene to allow detection of active
transcription from the 50LTR by measuring levels of GFP epifluo-
rescence (Jordan et al., 2003). First, our sequence analyses re-
vealed the sites of integration of theHIVgenome in three cell lines,
Figure 1. Transcription of a Gene with the Integrated
Viral Genome in J-Lat 9.2 and 15.4 Cells Yields Two
Different Forms of mRNA
(A and C) Schematic representations of the PP5 and UBA2
genes on the two homologous chromosomes in J-Lat 9.2 or
15.4 cells. The provirus is integrated into the intron 4 of the
PP5 gene (PP5* allele) or the intron 6 of the UBA2 gene
(UBA2* allele) as indicated. Black rectangles depict exons,
and white rectangles depict the 50 and 30LTRs. In the HIV ge-
nome, the nef gene was replaced by the GFP gene as indi-
cated by the hatched rectangle. Vertical arrows mark pA sites
in the PP5 or UBA2 gene and the two viral LTRs.
(B and D) Northern blotting was used to detect PP5 transcripts
from exon 1 to 3 and UBA2 transcripts from exon 2 to 6.
PP5mRNA and UBA2mRNA represent the full-length mRNA,
whereas PP5*mRNA and UBA2*mRNA correspond to the
truncatedmRNA transcribed from the PP5* andUBA2* alleles,
respectively.
(E) Northern blotting was used to detect transcripts containing
the LTR (281 to +3) in J-Lat 9.2 and 15.4 cells. Actin levels
were used for loading controls in northern blotting, and J-Lat
8.4 cells were used as the control.
J-Lat 9.2, 15.4, and 8.4. In the first one, the provirus
resides in the protein phosphatase 5 (PP5) gene and
in the second one, in the SUMO-activating enzyme
subunit 2 (UBA2) gene. In the J-Lat 8.4 cells, thepro-
virus is integrated in the DNA helicase V gene. All
three genes are constitutively transcribed, suggest-
ing that their expression may interfere with the viral
transcription. However, transcription from the host promoter
has the same directionality as the one from the viral 50LTR only
in J-Lat 9.2 and 15.4 cell lines. Although TI between two pro-
moters occurs independently of their orientation, it can be moni-
tored more easily when transcriptional directionalities are the
same. Hence, we focused on the J-Lat 9.2 and 15.4 cell lines
and used the J-Lat 8.4 cell line as a control throughout our study.
In J-Lat 9.2 cells, the provirus resides in intron 4 of the PP5
gene (PP5* allele) and in J-Lat 15.4 cells, in intron 6 of the
UBA2 gene (UBA* allele). Thus, both cell lines contain one allele
that corresponds to the wild-type gene (PP5 or UBA2) and the
other allele that contains the provirus (PP5* or UBA2*) (Figures
1A and 1C). Next, we determined transcriptional activities origi-
nating from the PP5 or UBA2 promoter. To detect transcription
originating from the wild-type and provirus-containing alleles,
we performed northern blotting using the total RNA from J-Lat
9.2 or 15.4 cells and a DNA probe complementary to the PP5
or UBA2 mRNA upstream of the viral-integration site (Figures
1B and 1D). As expected, we detected two bands with the
RNA from both cell lines (Figures 1B and 1D, lane 1). Whereas
the longer band represents the full-length wild-type mRNA, the
shorter one represents the truncated mRNA (*mRNA) tran-
scribed from the PP5* or UBA2* promoter. In contrast, only the
full-length PP5 or UBA2 mRNA was detected in the control
J-Lat 8.4 cell line (Figures 1B and 1D, lane 2). We conclude
that transcription originating from the PP5 or UBA2 promoter in
J-Lat 9.2 and 15.4 cells, respectively, results in a full-length
and a truncated transcript, owing to the integration of the HIV
provirus into the actively transcribed PP5 or UBA2 gene.124 Cell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc.
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and 15.4 Cells Contain Proviral Sequences
and Terminate in the 50LTR
To verify if PP5 and UBA2 *mRNAs contain the HIV LTR se-
quence, we first performed northern blotting with a DNA probe
containing a part of the LTR. Indeed, we detected single bands
of equal size to the previously observed *mRNAs in the RNA
from J-Lat 9.2 and 15.4 cells (Figure 1E), suggesting that they
represented transcripts originating from the host promoter and
terminating in the 50LTR. To further confirm this possibility, we
performed reverse transcription followed by PCR (RT-PCR) us-
ing the total RNA from J-Lat 9.2 or 15.4 cells and two different
primer pairs (Figures 2A and 2B). For each cell line, the pairs
shared the same forward primer (P1 or U1) but differed in the re-
verse primer, one of which annealed to the region upstream (H1)
and another downstream (H2) of the polyadenylation (pA) site in
the 50LTR (Figures 2A and 2B, top). Importantly, this analysis
yielded a fragment only with the P1/H1 (Figure 2A, lanes 1 and
2) or U1/H1 (Figure 2B, lanes 1 and 2) primer pair, demonstrating
the termination of the *mRNA at the pA site in the 50LTR. Se-
quencing of the amplified fragments confirmed the presence of
50LTR in *mRNAs and revealed the usage of a cryptic splice ac-
ceptor site in the intron preceding the 50LTR in both cell lines (see
Figures S1A and S1B available online).
To further characterize *mRNAs, we determined the ratio be-
tween levels of *mRNA and viral mRNA in J-Lat 9.2 or 15.4 cells.
To do so, we designed a modified quantitative RT-PCR (RT-
qPCR). Our modified method, herein named RT-DNA-qPCR
(RT-DqPCR), is based on the fact that the molar ratio between
Figure 2. TheHost-Viral Chimeric Transcripts in J-Lat 9.2 and
15.4 Cells Terminate in the 50LTR
(A and B) RT-PCR was used to determine the termination of
PP5*mRNA and UBA*mRNA. Schematic representations of a part of
the PP5* and UBA2* alleles with numbered exons (black rectangles)
and 50LTR (white rectangle) are presented on top. The vertical line in
the 50LTR represents the pA site. Primers used for amplification of
cDNA are marked above the schemes. Bottom panels show agarose
gels with fragments obtained by RT-PCR of the same sample. The
primer pairs used are denoted above the lanes.
(C) Schematic representations of a part of the PP5* and UBA2* alleles
with numbered exons (black rectangles) and 50LTR (white rectangle).
Primers used for amplification of cDNA corresponding to the trun-
cated transcripts are marked above the scheme.
(D) Ratio between *mRNA and HIV (Rev) mRNA in untreated (left panel)
or between HIV (Rev) mRNA and *mRNA in TNF-a-treated (right panel)
J-Lat 9.2 (white bars) and 15.4 (black bars) cells determined by
RT-DqPCR. Primers amplifying cDNA for truncated transcripts are
denoted for each of the two cell lines. Rev cDNA was amplified
with primer pair H13/H14 (Table S1). Values of amplified cDNA were
normalized to DNA amplified with the same primer pair. The results
for three RT-DqPCR assays are shown ± SEM.
two genes in genomic DNA is equal (see Supplemental
Text 1). In short, RT-DqPCR involves normalization of
values obtained by amplification of cDNA to those ob-
tained by amplification of genomic DNA with the same
primer pair that anneals to the respective exon se-
quences. Therefore, the method enables us to directly
compare the levels of two different transcripts. Impor-
tantly, using RT-DqPCR, we detected approximately 40-
or 58-foldmore *mRNA than viral mRNA in J-Lat 9.2 or 15.4 cells,
respectively (Figure 2D, bars 1 and 2). In contrast, this ratio be-
came reversed upon partial activation of viral transcription with
TNF-a. The ratios between the viral mRNA and *mRNA were
38- and 11-fold in J-Lat 9.2 and 15.4, respectively (Figure 2D,
bars 3 and 4). Using RT-DqPCR, we further assessed levels of
*mRNA relative to those of full-lengthmRNA (Figure S2). Interest-
ingly, levels of PP5 *mRNAwere 103 lower compared to levels of
PP5 mRNA (Figure S2A), whereas levels of UBA2 *mRNA were
slightly higher than those of UBA2 mRNA (Figure S2B). The dis-
similar ratios could be attributed to different transcript stabilities,
which might reflect the nature of processing of nascent mRNAs.
Also, differential expression from the two homologous alleles is
possible. Nevertheless, these results are in a good agreement
with the findings obtained by northern blotting (Figures 1B and
1D). Taken together, the *mRNAs represent the host-viral chime-
ric transcripts, which contain sequences of the 50LTR and termi-
nate at its pA signals. In addition, RT-DqPCR revealed that levels
of *mRNA exceed those of viral mRNA in unstimulated cells,
suggesting that transcription originating from the host genes
in J-Lat 9.2 and 15.4 cells may antagonize proviral transcription.
Host-Viral Chimeric Transcripts Are Indicators of Active
Transcription Upstream of the 50LTR
Existence of the host-viral chimeric transcripts that originate
from a host promoter and include 50LTR could be useful for iden-
tifying ongoing transcription upstream of the 50LTR indepen-
dently of the site of viral integration. Therefore, we next devised
an assay, which determines the ratio between transcriptsCell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc. 125
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present solely in the viral mRNA. For these experiments, we em-
ployed RT-DqPCR and used primer pairs specific for LTR-con-
taining and Rev- or Env-containing transcripts. To ensure that
we measured the same viral transcripts, all primer pairs were se-
lected after the last splice donor site in the HIV-nascent mRNA.
The values obtained with the LTR-specific primers represent
a sum of transcripts originating from the host promoter and of vi-
ral transcripts, which also contain LTR sequence at their 30 ends.
Therefore, the measured ratio corresponds to the equation (a +
b)/b, where ‘‘a’’ is the number of host-viral chimeric transcripts
and ‘‘b’’ is the number of viral transcripts (see Supplemental
Text 2). First, we determined this ratio in J-Lat 9.2 or 15.4 cells
and found that it was 35 or 55 (Figure 3A, bars 1–4). These results
were comparable to the ones obtained with primers specific for
*mRNA (Figure 2D, bars 1 and 2). In contrast, this ratio was 1 in
TNF-a-treated cells (Figure 3A, bars 5–8), indicating that
approximately 20% activation of viral transcription (see below)
already precludes detection of the upstream transcription. This
finding is not surprising, as we demonstrated that there is 11-
fold or 38-fold more viral mRNA than *mRNA in TNF-a-treated
cells (Figure 2D, bars 3 and 4). Predictably, our control experi-
ments demonstrate that the ratio between the Rev- and Env-
containing transcripts was 1 in untreated and TNF-a-treated
cells (Figure 3A, bars 9–12).
Next, we determined a threshold at which upstream transcrip-
tion is still detectable using this method. Here, we used J-Lat
15.4 cells with different levels of viral expression obtained by
mixing the cDNA of untreated and TNF-a-treated cells (Figures
3B and S3). We decided to use this cell line because of a smaller
ratio between HIV transcripts and *mRNA in these cells com-
pared to those in J-Lat 9.2 cells (Figure 2D, bars 3 and 4). The ra-
tio between LTR- and Rev-containing transcripts increased with
the decreased levels of viral expression consistent with the ratio-
nal equation (see Supplemental Text 2) and revealed that the
upstream transcription can be detected when viral transcription
is activated for less than 10% (Figure 3B). Taken together, the
host-viral chimeric transcripts could be exploited for identi-
fication of the host transcription upstream of 50LTR. In addition,
because of the presence of 50LTR in these transcripts, the
upstream transcription could be detected independently of
the viral-integration site.
HIV-Infected Primary CD4+ T Cells Contain Significant
Levels of Transcription Upstream of the 50LTR
To identify transcription upstream of the 50LTR in HIV-infected
peripheral blood lymphocytes (PBLs), we used the above
method. After activation of HIV-infected PBLs with IL-2 and
PHA, we rested them and isolated CD4+ T cells. We measured
viral production from activated PBLs and CD4+ T cells using
p24 ELISA and found that activated PBLs produced 5.5-fold
more viral particles (Figure 3C, bars 1 and 2). Although CD4+
T cells still produced modest levels of viruses, we detected the
transcription upstream of the 50LTR as the ratio between LTR-
containing and Rev- or Env-containing transcripts; the ratio
was 2 (Figure 3D, bars 1 and 3). This ratio corresponded to the
one in J-Lat 15.4 cells with about 2% of activated viral transcrip-
tion (Figure 3B). On the contrary, the upstream transcription was
not detected in activated PBLs (Figure 3D, bars 2 and 4). As126 Cell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevieexpected, the ratio between Rev-and Env-containing transcripts
was 1 in CD4+ T cells as well as in activated PBLs (Figure 3D,
bars 5 and 6). We conclude that HIV-infected primary CD4+
T cells contain significant levels of the host-viral chimeric tran-
scripts. Because they indicate active transcription upstream
of the 50LTR, these findings suggest that viral transcription is
subjected to TI in these cells.
Transcriptional Interference by theActively Transcribed
Host Gene Reverses Viral Transcription
from the 50 to the 30LTR
Next, we investigated in detail how active transcription of the
upstream PP5* or UBA2* gene affects transcription from both
Figure 3. Identification of Upstream Transcription in J-Lat Cells and
HIV-Infected Primary CD4+ T Cells
(A) Ratios between mRNAs containing LTR and Rev or Env in untreated (the
two upper left panels) or TNF-a-treated (the two upper-right panels) J-Lat
9.2 (white bars) and 15.4 (black bars) cells as determined by RT-DqPCR are
shown. Lower panels represent ratios between mRNAs containing Rev and
Env in untreated (left) or TNF-a-treated (right) cells.
(B) Ratios between mRNAs containing LTR and Rev in J-Lat 15.4 cells with dif-
ferent levels of viral expression (designated as percentage of GFP+) as deter-
mined by RT-DqPCR.
(C) Viral production as assessed by p24 ELISA of HIV-infected CD4+ T cells
(black bar) and activated PBLs (white bar). The results for two assays are
shown ± SEM.
(D) Ratios between mRNAs containing LTR and Rev (left panel), LTR and Env
(middle panel), andRev andEnv (right panel) in CD4+ T cells (black bars) and ac-
tivated PBLs (white bars) as determined by RT-DqPCR. In the RT-DqPCR as-
says, the values of amplified cDNA were normalized to DNA amplified with the
sameprimer pair (seeH11/H12 in LTR,H13/H14 inRev,H15/H16 in Env in Table
S1). In (A), (B), and (D), the results for threeRT-DqPCRassaysare shown±SEM.r Inc.
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the case of active provirus, transcription originating from the
50LTR interferes with transcription from the 30LTR (Cullen
et al., 1984). Thus, we hypothesized that a similar TI is taking
place in latent J-Lat 9.2 and 15.4 cell lines, in which the ongoing
transcription from the host gene would interfere with transcrip-
tion from the 50LTR. Consequently, due to the premature termi-
nation of *mRNA at the pA site in the 50LTR, the 30LTR would no
longer be subjected to TI and could thus be activated. To test
this hypothesis, we activated viral-gene expression with Tat
or TNF-a and compared transcription from both LTRs to corre-
sponding transcription in untreated J-Lat 9.2 (Figure 4A) or 15.4
(Figure 4B) cells. We measured the activation of transcription
using RT-qPCR with two primer pairs that distinguish tran-
scripts from the two LTRs. Indeed, whereas the expression of
Tat resulted in only 3-fold amplification of transcripts initiating
from the 50LTR (Figures 4A and 4B, bar 2), treatment of the cells
with TNF-a resulted in 100- or 200-fold amplification (Figures
4A and 4B, bar 3) when compared to that from untreated cells.
In sharp contrast, both activators profoundly stimulated tran-
scription from the 30LTR in both cell lines. Tat expression re-
sulted in 100- or 250-fold amplification of transcripts initiating
Figure 4. Upstream Transcription Interferes with
the Activation of 50 but Not 30LTR in J-Lat 9.2 and
15.4 Cells
(A and B) Cells were electroporated with Tat (hatched
bars) or induced with TNF-a (black bars), and activation
of transcription from the 50 (left diagram) and the 30LTR
(right diagram) was determined using RT-qPCR. Levels
represent fold amplification of cDNA from treated (Tat or
TNF-a) cells over cDNA from untreated (mock, white
bars). Values in different samples were normalized to
the GAPDH signal. The results for four independent
RT-qPCR assays are shown ± SEM. Schematic represen-
tations of the HIV genome in J-Lat 9.2 and 15.4 cells are
presented below the RT-qPCR data. On both LTRs, bind-
ing sites for Sp1 and pA sites are marked. The horizontal
arrow above the gene designates ongoing transcription
from thePP5* andUBA2* promoters. Primers used for am-
plification of transcripts from the 50 and 30LTRs aremarked
above the scheme.
(C and D) RT-PCR was used to determine activation of
transcription from the 30LTR. Schematic representations
of a part of the PP5* and UBA2* alleles with numbered
exons (black rectangles) and the 30LTR (white rectangle)
are presented on top. Primers used for amplification of
fragments from cDNA aremarked above the scheme. Bot-
tom panels show agarose gels with fragments obtained by
RT-PCR from untreated () or TNF-a-treated (+) J-Lat 9.2
and 15.4 cells. The primer pairs used are written above the
lanes. The right panels represent a normalizing control.
from the 30LTR (Figures 4A and 4B, bar 5),
and exposure of cells to TNF-a led to 1300-
or 3000-fold amplification (Figures 4A and 4B,
bar 6). The same primer pairs (H5/H2 and H5/
P3 or H6/U3) were used in RT-PCR to estimate
absolute levels of transcription in unstimulated
and TNF-a-treated J-Lat 9.2 (Figure S4A) and
15.4 (Figure S4B) cells. This confirmed that
TNF-a treatment activated the 30LTR to a larger extent than
the 50LTR (Figures S4A and S4B, compare lanes 1 and 2 to
lanes 3 and 4). In addition, we performed RT-PCR with primer
pairs that amplify longer fragments from transcripts originating
from the 30LTR (Figures 4C and 4D). Here, no transcripts what-
soever could be detected in unstimulated cells, whereas signif-
icant levels were detected in TNF-a-treated cells (Figures 4C
and 4D, lanes 1 and 2). Importantly, treatment of cells with
TNF-a did not affect levels of PP5 or UBA2 transcripts (Figures
4C and 4D, lanes 3 and 4). Sequencing of these fragments re-
vealed a cryptic splice donor site in the 30LTR in both cell lines
(Figures S1C and S1D). Therefore, these transcripts contain
a part of the 30LTR followed by the host gene exons spliced
at the appropriate splice sites. Taken together, our results
indicate that the latent provirus in J-Lat 9.2 and 15.4 cells is
subjected to TI. Active transcription from the upstream gene
interferes with transcription from the 50LTR. As a consequence,
transcription can be activated from the 30LTR. Thus, TI medi-
ated by active transcription from a host gene switches tran-
scriptional activation from the 50 to the 30LTR. Importantly,
both LTRs are silent in unstimulated cells, suggesting that
although the 30LTR is probably not affected by the upstreamCell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc. 127
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transcription from this promoter.
Figure 5. Occupancy of Sp1, RNAPII, PS2-RNAPII, and
PS5-RNAPII on the HIV Genome Confirms that Transcrip-
tion from the 50LTR Is Inhibited
(A) Schematic representation of the HIV genome in intron 4 of
the PP5* gene. Primers used for amplification of immunoprecip-
itated DNA with qPCR are depicted with arrows above the
gene.
(B–E) ChIP-qPCR was performed on untreated (mock, white
bars) and TNF-a-treated (black bars) J-Lat 9.2 cells. Results
are presented as fold enrichment over a no-antibody control.
DNA was immunoprecipitated with antibodies against Sp1,
RNAPII, PS2-RNAPII, and PS5-RNAPII as depicted above the
panels. The primer pairs used are indicated below the bars.
The results for at least three ChIP-qPCR assays are shown ±
SEM.
pancy at the 50 and 30LTR, respectively (Figure 5B,
bars 4 and 8). The enrichment of Sp1 was promoter
specific as we failed to detect any Sp1 at the PP5*/
50LTR junction or in the coding region of the HIV ge-
nome (Figure 5B, bars 1, 2, 5, and 6). Thus, the ab-
sence of Sp1 at the 50LTR in untreated cells is a result
of TI due to the actively transcribed PP5* gene. The
finding that TNF-a stimulation increased the levels of
Sp1 not only at the 30 but also at the 50LTR indicates
that stimulating PIC assembly on the latter promoter
can partially antagonize TI caused by the ongoing transcription
of the upstream host gene.Occupancy of Sp1 at the 50 but Not 30LTR Is Decreased
by the Actively Transcribed PP5* Gene
To demonstrate further TI of the 50LTR by the actively transcribed
host gene, we examined the occupancy of Sp1 and RNAPII
at both LTRs in J-Lat 9.2 cells using quantitative chromatin
immunoprecipitation (ChIP-qPCR) assay (Figure 5). This analysis
was performed on samples from untreated cells or cells treated
with TNF-a. To distinguish between Sp1 and RNAPII occupan-
cies at the two LTRs, two discriminating primer pairs were
used for amplifying fragments of the 50 and the 30LTR, respec-
tively (Figure 5A, H7/H8 and H7/P7). As a control, the occupancy
of the same proteins was determined at the PP5*/50LTR junction
and in the coding region of the viral genome (Figure 5A, P2/H3
and H9/H10).
First, we performed ChIP-qPCR with an antibody against
Sp1. We decided to follow the Sp1 gene occupancy because
previous studies demonstrated its role in the stimulation of
PIC assembly and transcription initiation (Jones et al., 1986).
More importantly, studies of the two consecutive HIV-derived
promoters that were integrated into the genome of HeLa cells
have established that Sp1 binding to the downstream promoter
was reduced only in the presence of the active transcription
originating from the upstream promoter (Greger et al., 1998).
Therefore, the lack of Sp1 promoter occupancy can be used
as a marker for TI. Indeed, no Sp1 could be detected at the
50LTR in unstimulated cells. On the contrary, there was about
3.5-fold enrichment of this protein at the 30LTR under the
same conditions (Figure 5B, bars 3 and 7). Moreover, TNF-a
stimulation led to a 4-fold and 7-fold enrichment of Sp1 occu-128 Cell Host & Microbe 4, 123–133, August 14, 2008 ª2008 ElsevieElongating RNAPII from the Actively Transcribed PP5*
Gene Interferes with Initiating RNAPII Only at the 50LTR,
which Is Opposed by Treatment with TNF-a
Next, we followed the occupancy of total RNAPII, RNAPII phos-
phorylated on Ser2 of the CTD (PS2-RNAPII), and RNAPII phos-
phorylated on Ser5 of the CTD (PS5-RNAPII) at the same geno-
mic regions under the same cell-culture conditions as above.
Levels of PS2-RNAPII indicate the presence of elongating
RNAPII, whereas levels of PS5-RNAPII mark initiating RNAPII.
We first detected a modest enrichment of total RNAPII at both
LTRs (7-fold and 3-fold, respectively) in unstimulated cells
(Figure 5C, bars 3 and 7). This RNAPII occupancy was further in-
creased in TNF-a-treated cells with a significantly greater enrich-
ment at the 30LTR (30-fold and 255-fold, respectively) (Figure 5C,
bars 4 and 8). Critically, in unstimulated cells, PS2-RNAPII occu-
pied only the 50LTR (10-fold enrichment) (Figure 5D, bars 3 and 7).
Furthermore, at the 50LTR, these levels were increased mini-
mally upon TNF-a stimulation. However, the stimulation led to
a dramatic (52-fold) enrichment of PS2-RNAPII at the 30LTR (Fig-
ure 5D, bars 4 and 8). Unlike the PS2-RNAPII occupancy, almost
no PS5-RNAPII could be detected at the 50LTR in unstimulated
cells. In contrast, PS5-RNAPII was present at the 30LTR in unsti-
mulated cells (11-fold enrichment) (Figure 5E, bars 3 and 7). Fi-
nally, both LTRs exhibited further enrichments of PS5-RNAPII
upon TNF-a treatment (25-fold and 80-fold, respectively) (Fig-
ure 5E, bars 4 and 8). Predictably, about 6-fold and 8-fold enrich-
ment of RNAPII and PS2-RNAPII was observed at the PP5*/
50LTR junction in unstimulated cells (Figure 5C, bars 1 and 2),
which was slightly decreased in TNF-a-treated cellsr Inc.
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RNAPII, as well as its phosphorylated forms, was observed in
the coding region in unstimulated cells. TNF-a stimulation led
to the significant enrichment of RNAPII (15-fold), PS2-RNAPII
(8-fold), and PS5-RNAPII (17-fold) (Figures 5C–5E, bars 5 and
6). Taken together, these ChIP-qPCR results strongly suggest
that a hallmark of the latent provirus in J-Lat 9.2 cells is TI of
the 50LTR caused by the transcription of the host PP5* gene.
This interfering transcription results in the lack of Sp1 and the
presence of the elongating RNAPII at the 50LTR. Moreover, TI
can be partially rescued by TNF-a stimulation, as documented
by the appearance of Sp1 and initiating RNAPII at the 50LTR.
The slight enrichment of the RNAPII in the coding region of unsti-
mulated cells might be attributed to some readthrough transcrip-
tion from the host gene. However, the enrichments of RNAPII,
PS2-RNAPII, and PS5-RNAPII in TNF-a-stimulated cells are still
much greater at the 30LTR. These results are understandable
since TNF-a activates the 50LTR in only 20% of cells (see below).
Consequently, the 30LTR is not interfered by transcription from
the 50LTR in 80% of cells and therefore, can be activated by
TNF-a.
Inhibition of Transcription from the PP5* Gene
Decreases Transcriptional Interference andCooperates
with TNF-a for Stimulating HIV Gene Expression
Thus far, we have established that TI by the actively transcribed
host gene prevents the transcription from the 50LTR and that
TNF-apartially reverses this effect. Next, we askedwhether a de-
crease of TI through inhibiting transcription from the promoter
upstream of the 50LTR would increase transcriptional activation
from this LTR (Figure 6). Here we focused on the J-Lat 9.2 cell
line, since it has been demonstrated that transcription from the
PP5 promoter could be reduced through inhibiting estrogen
receptor (ER) (Urban et al., 2001). Therefore, we established
J-Lat 9.2 and control J-Lat 8.4 cell lines that stably express
miRNA-adapted shRNA (shRNAmir) against the ERa mRNA
(J-Lat 9.2 shER and J-Lat 8.4 shER, respectively). In both J-Lat
shER cell lines, the ERa levels were decreased by 70%–80%
(Figure 6A) without affecting levels of glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) protein. Expectedly, this de-
crease led to a 50% inhibition of the PP5 mRNA levels in both
cell lines (Figure 6B). To examine how a decrease of transcription
originating from the PP5* promoter influenced transcription from
the 50LTR, we compared GFP expression of parental and J-Lat
shER cells using fluorescence-activated cell sorting (FACS). As
expected, no GFP-expressing cells could be detected in un-
treated cells (Figures 6C–6F, mock). About 20% of cells turned
GFP positive in TNF-a-treated J-Lat 9.2 cells (Figure 6C, TNF-a).
Importantly, the inhibition of PP5 transcription synergized
with TNF-a to increase further the number of GFP-expressing
cells to 44% (Figure 6D, TNF-a). On the other hand, the number
of GFP-expressing cells remained the same (13%) in J-Lat 8.4
and J-Lat 8.4 shER cell lines (Figures 6E and 6F, TNF-a), ruling
out any nonspecific effect of shRNA against the ERa mRNA. In
addition, a control shRNA in the J-Lat 9.2 cells did not result in
increased transcription from the 50LTR (data not shown). Thus,
the inhibition of transcription from the PP5* gene decreased TI
of the 50 LTR, which resulted in its increased activation by
TNF-a.Cell HoCooperative Activation of the 50LTR Overcomes
TI and Stimulates HIV Gene Expression
The results above illustrated that the inhibition of an active host
transcription upstream of the 50LTR led to the increased tran-
scriptional activation of the provirus. In contrast to the viral inte-
gration-specific transcriptional activation in J-Lat 9.2 cells, we
next undertook an approach that should be independent of the
host gene into which the provirus integrated and could be ap-
plied in general for the reactivation of proviruses from latency
(Figure 7). We reasoned that a potent activation of the 50LTR
could overcome the upstream transcription and thus effectively
counteract TI. To activate 50LTR, we employed TNF-a, hexam-
ethylene bisacetamide (HMBA), and Tat. Whereas TNF-a po-
tently stimulates transcription initiation, the latter two activate
transcription elongation by releasing and/or recruiting the active
P-TEFb, respectively (Contreras et al., 2007; Wei et al., 1998).
For these experiments, we again used the J-Lat 9.2, 15.4, and
8.4 cell lines and followed the activation of viral transcription
by counting GFP-expressing cells using FACS. First, we found
that HMBA treatment alone led to a minimal increase in the num-
ber of GFP-expressing cells and, as expected, about 20% of
TNF-a-treated cells became GFP positive (Figures 7A–7C,
HMBA and TNF-a). However, a combined treatment of cells
with HMBA and TNF-a resulted in a much greater activation of
viral transcription (50%–60% of GFP-expressing cells) in the
cell lines tested (Figures 7A–7C,HMBA+TNF-a). Of note, a com-
binatorial treatment with HMBA and TNF-a also increased viral
production in HIV-infected resting CD4+ T cells (Figure S5, bar 2).
Next, we tested the effect of Tat on transcription of the provi-
rus. In agreement with the results in Figure 4, expression of Tat
alone exerted minimal stimulatory effect on the 50LTR (Figures
7A–7C, Tat). However, in combination with TNF-a, Tat expres-
sion activated viral transcription greatly (70%–80% of GFP-ex-
pressing cells) in all three cell lines (Figures 7A–7C, Tat + TNF-a).
We further investigated the ability of PMA, another known
stimulator of viral transcription, to activate the 50LTR in latent
J-Lat cells. Treatment of cells with PMA stimulated transcrip-
tional activation-form HIV promoter to the same extent as
TNF-a (Figures S6A–S6C). Finally, we compared levels of *mRNA
in J-Lat 9.2 and 15.4 cells treated with TNF-a alone (Figure 7D,
bars 2 and 6) and in combination with HMBA (Figure 7D, bars
3 and 7) or Tat (Figure 7D, bars 4 and 8) to levels in untreated cells
(Figure 7D, bars 1 and 5). Interestingly, *mRNA levels decreased
concomitantly with the increased activation of transcription from
the 50LTR in both cell lines. Probably, the formation of the PIC at
the 50LTR prevents the elongating RNAPII from the upstream
promoter to transcribe through this LTR, resulting in the degra-
dation of nonpolyadenylated transcripts. Taken together, syner-
gistic activation of the viral promoter overcomes the upstream
host transcription and thus, effectively counteracts TI.
DISCUSSION
Understanding mechanisms that direct the establishment and
maintenance of HIV latency is critical for developing strategies
to eradicate the viral reservoir. In this study, we found that TI is
an important mechanism that contributes to viral latency in latent
J-Lat cells as well as in HIV-infected primary CD4+ T cells.st & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc. 129
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scriptional and posttranscriptional mechanisms contribute to
the postintegration form of viral latency (Lassen et al., 2004).
In addition, it was reported that the HIV genome integrates fre-
quently in transcription units (Han et al., 2004; Lewinski et al.,
2005). In the present work, we extended this knowledge by a de-
tailed analysis of how TI impacts viral transcription in latent
cells. Although TI occurs regardless of the orientation of the
two promoters, we studied TI phenomena in two J-Lat cell lines
with the same orientation of the host and viral promoters, which
allowed us to detect and analyze truncated transcripts originat-
ing from a host promoter and transcribing through the 50LTR.
The use of cryptic splice acceptor sites in the introns upstream
of the 50LTR in both cell lines resulted in inclusion of the LTR se-
quence in the processed transcript. Since cryptic splice sites
are plentiful in genes, and they are recognized by the spliceo-
some when there is no stronger splice site downstream of
them, such aberrant splicing probably takes place in many
cases of integration of the viral genome. On one hand, these
transcripts reflected active transcription upstream of the provi-
rus in both J-Lat cell lines. On the other hand, LTR sequence
in the transcripts enabled us to use them as indicators of TI
in general. Importantly, with this approach we detected TI in
primary CD4+ T cells. The limitations of the method applied
here are that proviral expression has to be low for the host trans-
cription at the 50LTR to be detectable. Since primary CD4+
T cells used here produced modest levels of viral particles,
we speculate that average levels of host-viral chimeric trans-
cripts in these cells exceed those in the two J-Lat cell lines.
These results thus suggest that TI plays a key role in primary
CD4+ T cells.
Figure 6. Knockdown of ERa in J-Lat 9.2 Cells Inhibits
Transcription from the PP5* Promoter and Activates
Transcription from the 50LTR
(A) Western blotting of endogenous ERa and GAPDH in cellu-
lar lysates from J-Lat 9.2, J-Lat 9.2 shER, and a control J-Lat
8.4 shER cells are indicated.
(B) RT-qPCR with a primer pair amplifying exon 2 of the PP5
gene was used to measure the inhibition of transcription
from the PP5 promoter in J-Lat (white bars) and J-Lat shER
(black bars) cells as indicated. The results for three RT-DqPCR
assays are shown ± SEM.
(C–F) Histograms obtained with FACS of untreated (mock) and
TNF-a-treated cells. Cell lines used are indicated on top of the
panels. Numbers represent the percentage of GFP-positive
cells indicated by horizontal lines.
In J-Lat 9.2 and 15.4 cells, the host-viral chimeric
transcripts terminated at the pA site in the 50LTR,
but transcripts initiating at the host promoter and
terminating at the pA site in the 30LTR were not ob-
served. Overall, these results are in agreement with
studies demonstrating that the pA site in the 50LTR
is recognized if it is at a sufficient distance from the
transcription start site (Cherrington and Ganem,
1992). Nevertheless, we do not exclude the possi-
bility of some transcription through the provirus,
since slight enrichment of elongating RNAPII in
the HIV coding region of transcriptionally silent
J-Lat 9.2 cells was observed using ChIP-qPCR assay. However,
transcription originating from the host promoter, ignoring pA
sites in both LTRs and consequently splicing out the provirus
together with the host intron (Han et al., 2004), is most likely
less frequent than transcription terminating in the 50LTR. Our
finding that the latent provirus exhibited active transcription orig-
inating from the 30 but not 50LTR upon Tat expression as demon-
strated with RT-qPCR is also in support of this notion. Also, the
30LTR was considerably more responsive to TNF-a stimulation
than the 50LTR, suggesting that the latter LTR is much strongly
subjected to TI. Even if there is transcription from host gene
‘‘reading through’’ both LTRs in some latent cells, this does not
diminish the impact of TI on the 50LTR.
In addition to the transcript analysis fromboth LTRs, a series of
ChIP-qPCR assays in J-Lat 9.2 cells complemented nicely the
RT-qPCR results. Accordingly, the active PP5* transcription co-
incided with the lack of Sp1 and with the occurrence of elongat-
ing RNAPII at the interfered 50LTR in unstimulated cells. Further-
more, TNF-a stimulation led to the appearance of Sp1 and
initiating RNAPII on the 50LTR and additional enrichments of ini-
tiating and elongating RNAPII on the 30LTR. These effects are
most likely achieved through the activation of NF-kB,which stim-
ulates several steps of viral transcription including the PIC forma-
tion, transcription initiation, and transcription elongation. Thus,
our findings lead us to propose a model for TI, in which the elon-
gating RNAPII transcribes the host gene through the 50LTR, thus
physically antagonizing the formation of the PIC on the viral
promoter. Hence, effective transcription from the 50LTR cannot
ensue and consequently, the integrated virus remains dormant.
In contrast, we demonstrated that TI could be counteracted
by specific inhibition of the upstream transcription or by130 Cell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc.
Cell Host & Microbe
Transcriptional Interference Promotes HIV LatencyFigure 7. TNF-a,Together with HMBA or Tat, Act Synergistically to Activate Transcription from the 50LTR
(A–C) Histograms obtained with FACS analysis of J-Lat 9.2, 15.4, and 8.4 cells. The numbers represent the percentage of GFP-positive cells (indicated by hor-
izontal lines). Cells were untreated (mock), or treated with HMBA (HMBA), expressed Tat (Tat), treated with TNF-a alone (TNF-a), or in combination with HMBA
(HMBA + TNF-a) as shown on top of each histogram. The last histograms on the right represent cells expressing Tat that were treated with
TNF-a (Tat + TNF-a).
(D) Relative quantity of PP5* (left panel) and UBA2* (right panel) mRNAs in untreated (mock, white bars), TNF-a treated (black bars), HMBA + TNF-a treated
(hatched bars), and cells expressing Tat that were treated with TNF-a (checkered bars), as determined using RT-qPCR. Primer pairs are denoted above the
diagrams. Values in different samples were normalized to the GAPDH signal. The results for three independent RT-qPCR assays are shown ± SEM.cooperative activation of transcription initiation and elongation
from the 50LTR by the viral and host TFs. In the latter scenario,
we envision that RNAPII initiating from the viral promoter com-
petes successfully with the RNAPII that is elongating through
the 50LTR. Because the potent activation of the 50LTR is indepen-
dent of the integration site of the provirus, it could be applied
generally for overcoming TI in principle. This would lead to the re-
activation of the latent viruses, which is thought to be a prerequi-
site for its elimination from the host (Finzi et al., 1999).
Given the preferential integrations of viral genomes into active
transcription units, we hypothesize that TI is a widespread event,Cell Howhich silences expressions of the invading proviruses. Notably,
TI could operate in concert with already established mecha-
nisms. For example, its occurrence could be instrumental in rest-
ing cells, where key host and viral TFs are limiting and thus can-
not overcome TI for effective viral gene expression. In addition, it
is possible that the presence of a repressive deacetylated chro-
matin that has been observed on the 50LTR (Van Lint et al., 1996)
as well as methylated DNA in this region (Bednarik et al., 1987) is
a consequence of an elongating RNAPII from the actively tran-
scribed host gene that reads through the viral promoter. Indeed,
studies in yeast have determined that the eviction of histones inst & Microbe 4, 123–133, August 14, 2008 ª2008 Elsevier Inc. 131
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tion behind RNAPII, where they further undergo deacetylation by
the cotranscriptionally recruited HDACs (Kaplan et al., 2003;
Li et al., 2007). This mechanism helps to ensure that cryptic
promoters within the transcribed genes do not function as trans-
cription start sites. Therefore, 50LTRs of the proviruses that are
integrated within actively transcribed host genes may represent
just such cryptic promoters that need to be silenced. Thus, mul-
tiple mechanisms operating at the level of gene expression act
cooperatively to establish and maintain HIV latency.
In conclusion, our study reveals that TI represents a keymech-
anism that antagonizes proviral gene expression to promote the
latency of HIV. Furthermore, it demonstrates several means that
could be used to counteract TI for reactivating latent HIV. Future
mechanistic studies linking TI and other transcriptional and post-
transcriptional blocks will yield a broader picture of all critical
factors responsible for the postintegration latency. These inves-
tigations could be of help in devising strategies for eradicating
the latent reservoir.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions
J-Lat cells and the corresponding sequences flanking the viral genomes were
kindly provided by Dr. Eric Verdin and Dr. Dwayne A. Bisgrove. Cells were
grown in RPMI containing penicillin (100 IU/ml), streptomycin (100 mg/ml),
and 10% FBS at 37C with 5% CO2. Phoenix cells were grown in DMEM
containing penicillin (100 IU/ml), streptomycin (100 mg/ml), and 10% FBS at
37C with 5% CO2.
Northern Blotting
Total RNA was isolated from the cell pellet (3 3 107) with TRIzol Reagent
(Sigma) according to the manufacturer’s instructions. Northern blotting was
performed using NorthernMax Kit (Ambion) according to the manufacturer’s
instructions. The probes were amplified from cDNA synthesized with MMLV
Reverse Transcriptase (Invitrogen). PCR products were labeled with BioNick
Labeling System (Invitrogen).
Stimulation of J-Lat Cells and Detection of Activated Cells by Flow
Cytometry
Tat protein was expressed frompCDNA3 vector using electroporation of 107 J-
Lat cells resuspended in 300 ml of PBS at 230 V and 950 mF in Gene Pulser II
Electroporator (Bio-Rad). J-Lat cells were treated with 20 ng/ml TNF-a, 10 mM
HMBA, 100 nM PMA, or 100 nM TSA (all Sigma-Aldrich) for 24 hr and an-
alyzed on FACSCalibur Flow Cytometer (Becton Dickinson) using CellQuest-
Pro software. The results were analyzed with WinMDI 9.2 software.
Reverse Transcription Followed by PCR
Total RNA isolation and reverse transcription was performed as described
above. For RT-PCR and RT-qPCR, cDNA was synthesized with random hex-
amer primers (Invitrogen) and for RT-DqPCR analyzing HIV transcripts with
a specific primer (see primer H17 (F) in Table S1). Genomic DNA for RT-DqPCR
was isolated using DNeasy Blood and Tissue Kit (QIAGEN). Fold change be-
tween levels of two transcripts was obtained by normalizing values of amplified
cDNA to amplification of genomic DNA and determining ratio between the two
normalized values. From TNF-a-treated cells, RNA was isolated 24 hr after be-
ginning of the treatment and from cells expressing Tat protein, 48 hr after elec-
troporation. qPCR was performed in the presence of SyBr Green (Sigma).
Primer sequences and positions are in Table S1.
Construction of Stably Transfected Cell Lines
LMP vectors (Open Biosystems) expressing two microRNA-adapted shRNAs
(shRNAmir) against the ERa and a control shRNAmir (Table S1) were trans-
fected into Phoenix cells with FuGENE6 reagent (Roche Applied Science).
Forty-eight hours posttransfection, supernatant was collected and used for132 Cell Host & Microbe 4, 123–133, August 14, 2008 ª2008 Elseviethe infection of J-Lat 9.2 or 8.4 cells. Twenty-four hours postinfection, cells
with the integrated shRNAmir were selected with puromycin.
Western Blotting
Ten million J-Lat or J-Lat shER cells were lysed in 0.8 ml of lysis buffer A
(10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 2 mM EDTA, 1% NP-40, and 0.1%
protease inhibitor) for 40 min at 4C. Proteins in the lysates were separated
on SDS-PAGE electrophoresis. Western blotting was performed according
to the standard protocols with antibodies described in Table S2.
ChIP-qPCR Assays
Crosslinking was achieved by incubating 73 107 J-Lat 9.2 cells in 1% formal-
dehyde in medium for 10 min at room temperature. Crosslinking reactions
were stopped by addition of glycine to a final concentration of 0.125 M. Cells
were then pelleted in a conical tube and washed with cold phosphate-buffered
saline. Sonication and immunoprecipitation were performed using ChIP Assay
Kit (Upstate) according to themanufacturer’s instructions. Antibodies used are
presented in Table S2. As negative control, normal rabbit or mouse serum
(Sigma-Aldrich) was used. Appropriate primer pairs (Table S1) were used to
amplify specific DNA fragments with qPCR. Results were normalized to input
DNA and presented as fold enrichment over a no-antibody (serum) control.
Infection of PBLs and Isolation of Resting CD4+ T Cells
Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats of
healthy HIV negative donors in a Ficoll density gradient (Pharmacia). Isolation
of PBLs, their activation with PHA/IL-2, and infection with HIV-1LAI followed by
isolation of resting CD4+ T cells by negative selection using magnetic beads
(Invitrogen) was performed as previously described (Contreras et al., 2007).
Resting CD4+ T cells were treated with 1 mM HMBA and 10 ng/ml TNF-a
for 24 hr. Viral release in the supernatant was quantified by p24 ELISA
(PerkinElmer).
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